FDA applicant
Columbia Bioscience, Inc.
FDA records 13 decisions for Columbia Bioscience, Inc. (Columbia, MD) from 1996 to 1999: 13 510(k) clearances. Most are in product codes LSE (Epstein-Barr Virus, Other) and JZO (System, Test, Thyroid Autoantibody). Its devices cite 5 predicates, 0 of them its own earlier devices. 3 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Columbia Bioscience, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Columbia Bioscience, Inc. since 2007.
Recalls per year
1in 2018
Class I Class II/III not classified
Planning a device like Columbia Bioscience, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Columbia”
FDA records each applicant name separately; these may or may not be the same firm.